DailyDoctor Archive Specialties Get app
All emergency & critical care briefings

The edition · Emergency & Critical Care

Septic shock with cancer: hold transfusion at 7 g/dL

A French trial of liberal against restrictive transfusion in cancer patients with septic shock was stopped early, with no lactate or survival benefit and far more clots in the liberal arm. Plus automated oxygen titration, earlier vasopressin, and haloperidol by delirium subtype.

The edition in brief

Transfusion in septic shock with cancer: TRANSPORT randomised 187 adults with cancer, septic shock, lactate above 2 mmol/L and haemoglobin below 9 g/dL to transfusion thresholds of 9 or 7 g/dL for 48 hours. It was stopped early for safety. Twelve-hour lactate clearance was 52% against 50% (OR 1.07, 0.60–1.90), 28-day mortality 46% against 53% (not significant), and thrombotic events 13% against 1%. Closed-loop oxygen: seven randomised trials and 635 hospitalised adults on non-invasive oxygen found automated titration kept saturation within target about 21% more of the time than manual adjustment, more with low-flow than high-flow oxygen. Vasopressin timing: a target trial emulation in 3,810 adults whose noradrenaline reached 0.25 µg/kg/min found starting vasopressin within 3 hours was associated with lower 28-day mortality (48.1% against 53.0%) and less renal replacement therapy than starting at 3–6 hours. Haloperidol: a post hoc Bayesian analysis of the AID-ICU trial found haloperidol associated with benefit in both hypoactive and hyperactive delirium, with a moderate probability of a larger effect in hyperactive delirium.

In this edition

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for emergency & critical care, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free